Enhanced gene expression in lung by a stabilized lipoplex using sodium chloride for complex formation

被引:30
作者
Kawakami, S [1 ]
Ito, Y [1 ]
Fumoto, S [1 ]
Yamashita, F [1 ]
Hashida, M [1 ]
机构
[1] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Drug Delivery Res, Sakyo Ku, Kyoto 6068501, Japan
关键词
gene therapy; cationic liposomes; non-viral vectors; lipoplex; toxicity;
D O I
10.1002/jgm.813
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background In this study, we investigated the in vivo gene transfection efficacy of a `surface charge regulated' (SCR) lipoplex, dispersed in the presence of an essential amount of NaCl during lipoplex formation. Methods SCR lipoplexes were prepared and their physicochemical properties were analyzed. After intravenous (i.v.) administration, transfection efficacy, distribution characteristics, and liver toxicity were evaluated in mice. Results At NaCl concentrations of 10 mM, the particle sizes of the SCR lipoplexes were about 120 nm and were compatible with a conventional lipoplex. However, fluorescent resonance energy transfer analysis revealed that cationic liposomes in the SCR lipoplexes increased fusion. After i.v. administration, the transfection activity in the lung of the SCR lipoplex (10 mM NaCl solution in the lipoplex) was approximately 10-fold higher than that of the conventional lipoplex. Pharmacokinetic studies demonstrated a higher distribution in lung by the SCR lipoplex. When the gene expression levels of the SCR lipoplex and conventional lipoplex were compared, the SCR lipoplex at a dose of 30 mu g was compatible with that of the conventional lipoplex at a dose of 50 mu g. A significantly higher serum alanine aminotransferase (ALT) activity and TNF alpha concentration was observed by the conventional lipoplex (pDNA dose; 50 mu g), but this was not the case for the SCR lipoplex (pDNA dose; 30 mu g). Conclusions We demonstrated that the SCR lipoplex could enhance the transfection efficacy in the lung without increasing the liver toxicity. Hence, the information will be valuable for the future use, design, and development of lipoplexes for in vivo applications. Copyright (c) 2005 John Wiley & Sons, Ltd.
引用
收藏
页码:1526 / 1533
页数:8
相关论文
共 27 条
[1]   Lipoplex-mediated gene delivery to the lung occurs within 60 minutes of intravenous administration [J].
Barron, LG ;
Gagné, L ;
Szoka, FC .
HUMAN GENE THERAPY, 1999, 10 (10) :1683-1694
[2]   Enhanced hepatocyte-selective in vivo gene expression by stabilized galactosylated liposome/plasmid DNA complex using sodium chloride for complex formation [J].
Fumoto, S ;
Kawakami, S ;
Ito, Y ;
Shigeta, K ;
Yamashita, F ;
Hashida, M .
MOLECULAR THERAPY, 2004, 10 (04) :719-729
[3]   Analysis of hepatic disposition of galactosylated cationic liposome/plasmid DNA complexes in perfused rat liver [J].
Fumoto, S ;
Nakadori, F ;
Kawakami, S ;
Nishikawa, M ;
Yamashita, F ;
Hashida, M .
PHARMACEUTICAL RESEARCH, 2003, 20 (09) :1452-1459
[4]  
Harvie P, 2000, J PHARM SCI, V89, P652, DOI 10.1002/(SICI)1520-6017(200005)89:5<652::AID-JPS11>3.0.CO
[5]  
2-H
[6]   In vivo gene transfer by intravenous administration of stable cationic lipid DNA complex [J].
Hofland, HEJ ;
Nagy, D ;
Liu, JJ ;
Spratt, K ;
Lee, YL ;
Danos, O ;
Sullivan, SM .
PHARMACEUTICAL RESEARCH, 1997, 14 (06) :742-749
[7]   Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery [J].
Hong, KL ;
Zheng, WW ;
Baker, A ;
Papahadjopoulos, D .
FEBS LETTERS, 1997, 400 (02) :233-237
[8]   Evaluation by fluorescence resonance energy transfer of the stability of nonviral gene delivery vectors under physiological conditions [J].
Itaka, K ;
Harada, A ;
Nakamura, K ;
Kawaguchi, H ;
Kataoka, K .
BIOMACROMOLECULES, 2002, 3 (04) :841-845
[9]  
Kawakami S, 2002, CRIT REV THER DRUG, V19, P171
[10]   In vivo gene transfection via intravitreal injection of cationic liposome/plasmid DNA complexes in rabbits [J].
Kawakami, S ;
Harada, A ;
Sakanaka, K ;
Nishida, K ;
Nakamura, J ;
Sakaeda, T ;
Ichikawa, N ;
Nakashima, M ;
Sasaki, H .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 278 (02) :255-262